Lejla(Mutapcic)VajzovicMD

Ophthalmology • Durham, NC

Retinal Disease

Associate Professor, Adult and Pediatric Vitreoretinal Surgery and Diseases, Duke University Eye Center, Durham, NC

Join to view full profile

Dr. Vajzovic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vajzovic's full profile

Already have an account?

Office
2351 Erwin Road
Durham, NC 27705
Phone+1 919-684-4524

Fax+1 919-681-6474
Is this information wrong?

Education & Training

University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2008 - 2011
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2007 - 2008
Mayo Clinic College of MedicineClass of 2006

Certifications & Licensure

NC State Medical License 2011 - 2025
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy Start of enrollment: 2019 Nov 15
Completed
Phase 3
Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position Start of enrollment: 2020 Dec 10
Active, not recruiting
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Start of enrollment: 2020 Dec 04
Active, not recruiting
Phase 3
Roles: Contact
Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Start of enrollment: 2020 Dec 04
Active, not recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

3 citations
Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials.
Carl J Danzig, Arshad M Khanani, Peter K Kaiser, Margaret A Chang, Jaclyn L Kovach
Ophthalmology. Retina. 2024-05-07
32 citations
Argus II retinal prosthesis system: a review of patient selection criteria, surgical considerations, and post-operative outcomes
Avni P. Finn, Dilraj S. Grewal, Lejla Vajzovic
Clinical Ophthalmology. 2018-06-13
51 citations
The GLH proteins, Caenorhabditis elegans P granule components, associate with CSN-5 and KGB-1, proteins necessary for fertility, and with ZYX-1, a predicted cytoskelet...
Pliny A. Smith, W.-M. Leung-Chiu, Ruth Montgomery, April Orsborn, K. A. Kuznicki
Developmental Biology. 2002-11-15

Journal Articles

Comparison of Optical Coherence Tomography with Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease
Prithvi Mruthyunjaya, Cynthia A Toth, Sally S Ong, Lejla Vajzovic, JAMA

Press Mentions

RWC Update: RWC Young Retina Connect; Vitreoretinal Surgery in Uveitis; Ruptured Retinal Arterial Macroaneurysm with Secondary Branch Retinal Artery OcclusionApril 1st, 2023
An Engineer at Heart: Cynthia Toth's 25 Years of Revolutionizing Eye Care and SurgeryOctober 12th, 2022
ASRS Day 3: Subretinal Gene Therapy for Neovascular AMDOctober 12th, 2021
Join now to see all